FKBP
All Product Categories
-
FKBP Inhibitors
(11)
View all products
-
FKBP Agonists
(3)
View all products
-
FKBP Antagonist
(1)
View all products
-
FKBP Activators
(2)
View all products
-
FKBP Modulators
(4)
View all products
-
FKBP Degraders
(6)
View all products
-
FKBP Control
(1)
View all products
-
FKBP Substrate
(1)
View all products
-
FKBP Ligand
(1)
View all products
-
FKBP Related Products (40)
Related Products (40)
- 1
- 2
-
AP20187
0 ImagesSynonyms: B/B HomodimerizerAP20187 (B/B Homodimerizer) is a cell-permeable ligand used to dimerize FK506-binding protein (FKBP) fusion proteins and initiate biological signaling cascades and gene expression or disrupt protein-protein interactions.
-
SAFit2
0 ImagesSAFit2, a chemical probe, is a highly potent, highly selective FK506-binding protein 51 (FKBP51) inhibitor with a Ki of 6 nM and also enhances AKT2-AS160 binding.
-
Etonogestrel
0 ImagesSynonyms: 3-Oxodesogestrel; 3-keto-DesogestrelEtonogestrel (3-Oxodesogestrel), a biologically active metabolite of progestin Desogestrel, binds with high affinity to progesterone receptors and estrogen receptors in the target organs. Etonogestrel induce FKBP51 mRNA and protein expression in cultured human endometrial stromal cells (HESCs).
-
Everolimus (Standard)
0 ImagesSynonyms: RAD001 (Standard); SDZ-RAD (Standard)Everolimus (Standard) is the analytical standard of Everolimus. This product is intended for research and analytical applications. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities.
-
SAFit1
0 ImagesSAFit1 is a FK506 binding protein 51 (FKBP51)-specific inhibitor with a Ki of 4±0.3 nM.
-
dTAG-47-NEG
0 ImagesCat. No.: HY-147099Purity: 98.93%dTAG-47-NEG is an inactive bifunctional negative control PROTAC and also the diastereomer of dTAGV-1 (HY-145514D). dTAG-47-NEG does not reduce the level of BCL11A-FKBP12F36V, nor does it induce the degradation of BCL11A-FKBP12F36V, proteins tagged with FKBP12F36V, wild-type FKBP12, FKBP12F36V-KRASG12V or FKBP12F36V-EWS/FLI. dTAG-47-NEG exerts no antiproliferative effect in cancer cells.
-
Suc-Ala-Leu-Pro-Phe-pNA
0 ImagesSynonyms: Suc-ALPF-pNASuc-Ala-Leu-Pro-Phe-pNA (Suc-ALPF-pNA) is a synthetic polypeptide substrate that targets FK506-binding protein (FKBP). Suc-Ala-Leu-Pro-Phe-pNA can be used to determine peptidyl-prolyl cis-trans isomerase activity via the chymotrypsin-coupled assay. Suc-Ala-Leu-Pro-Phe-pNA serves as a substrate for human FK506-binding protein hFKBP-12 in the chymotrypsin-FKBP coupled PPIase assay. Suc-Ala-Leu-Pro-Phe-pNA is applicable for the detection and research of PPIase activity.
-
Everolimus-d4
0 ImagesSynonyms: RAD001-d4; SDZ-RAD-d4Everolimus-d4 is the deuterium labeled Everolimus. Everolimus (RAD001) is a Rapamycin derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities.
-
Zapalog
0 ImagesZapalog is a photocleavable small-molecule heterodimerizer that can be used to repeatedly initiate, and instantaneously terminate, a physical interaction between two target proteins. Zapalog dimerizes any two proteins tagged with the FKBP and DHFR domains until exposure to light causes its photolysis.
-
ElteN378
0 ImagesElteN378 is an inhibitors of FKBP12e. ElteN378 can be used in study Alzheimer disease, Parkinson disease, Amyotrophic Lateral Sclerosis, proliferation disorders and cancer.
-
GPI-1485
0 ImagesSynonyms: GM1485GPI-1485 (GM1485), a nonimmunosuppressive immunophilin ligand, promotes neurofunctional improvement and neural regeneration following stroke.
-
Ascomycin (Standard)
0 ImagesSynonyms: Immunomycin (Standard); FR-900520 (Standard); FK520 (Standard)Ascomycin (Standard) is the analytical standard of Ascomycin. This product is intended for research and analytical applications. Ascomycin (Immunomycin; FR-900520; FK520) is an ethyl analog of Tacrolimus (FK506) with strong immunosuppressant properties. Ascomycin is also a macrocyclic polyketide antibiotic with multiple biological activities such as anti-malarial, anti-fungal and anti-spasmodic. Ascomycin prevents graft rejection and has potential for varying skin ailments research[1][2].
-
FKBP51F67V-selective antagonist Ligand2
0 ImagesCat. No.: HY-153990CAS No.: 1680228-76-5FKBP51F67V-selective antagonist Ligand2 (example 3-3) is a potent FKBP51 F67V-selective antagonist ligand. FKBP51F67V-selective antagonist Ligand2 reverses the anxiogenic phenotype induced by overexpression of FKBP51 F67V in the amygdala. FKBP51F67V-selective antagonist Ligand2 binds to FKBP51 F67V, but not to wild-type FKBP51 or FKBP52.
-
FKBP51-Hsp90-IN-1
0 ImagesCat. No.: HY-158130CAS No.: 433313-64-5FKBP51-Hsp90-IN-1 (Compound D10) is a selective inhibitor of the FKBP51-Hsp90 protein-protein interaction, with an IC50 value of 0.1 μM against FKBP51. FKBP51-Hsp90-IN-1 can be used in the research of stress-related diseases, Alzheimer's disease, and metabolic disorders.
-
Setafrastat
0 ImagesCat. No.: HY-109102CAS No.: 1399715-48-0Synonyms: TS-133Setafrastat (Compound 40) is a hair growth stimulator.
-
FKBP12 PROTAC FM4
0 ImagesFKBP12 PROTAC FM4 is a PROTAC degrader of FKBP12, with a DC50 value of 0.09-0.22 nM. FKBP12 PROTAC FM4 inhibits global protein synthesis, induces apoptosis, and selectively reduces the viability of cervical cancer cells expressing MTH1-E6 and FKBP12F36V-tagged SARS1. FKBP12 PROTAC FM4 is applicable to research related to HPV-positive cervical cancer.
- 1
- 2
